L425 (Lacosamide 150 mg)
Pill with imprint L425 is Pink, Elliptical / Oval and has been identified as Lacosamide 150 mg. It is supplied by Alembic Pharmaceuticals Limited.
Lacosamide is used in the treatment of seizures and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 150 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for L425
Lacosamide
- Imprint:
- L425
- Strength:
- 150 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- Alembic Pharmaceuticals Limited
- National Drug Code (NDC):
- 46708-0173
More about lacosamide
- Lacosamide Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 103 Reviews
- Drug class: miscellaneous anticonvulsants
Consumer resources
- Lacosamide oral/injection
- Lacosamide Injection
- Lacosamide Oral Solution
- Lacosamide Tablets
- Lacosamide (Advanced Reading)
- Lacosamide Intravenous (Advanced Reading)
Other brands: Vimpat
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
